Maria Apostolopoulou

Maria Apostolopoulou

Auto-generated profile, based on publicly available information

Maria Apostolopoulou

Zentrum für Endokrinologie, Diabetologie, Rheumatologie, ÜBAG MVZ Dr. Eberhard und Partner und Klinikum Dortmund, Dortmund, Germany

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2021 in Science Advances
Verified
Journal Article
Open access
MAMaria Apostolopoulou
Maria Apostolopoulou
LMLucia Mastrototaro
Lucia Mastrototaro
SHSonja Hartwig
Sonja Hartwig
DPDominik Pesta
Dominik Pesta
KSKlaus Straßburger
Klaus Straßburger
MRMichael Roden
Michael Roden
SEV may serve as new biomarkers for predicting the individual response of insulin sensitivity to exercising.

11 March 2022 in Diabetologia
Verified
Journal Article
Open access
PDF file
GBGidon J Bönhof
Gidon J Bönhof
ASAlexander Strom
Alexander Strom
MAMaria Apostolopoulou
Maria Apostolopoulou
YKYanislava Karusheva
Yanislava Karusheva
TSTheresia Sarabhai
Theresia Sarabhai
DZDan Ziegler
Dan Ziegler
Aims/hypothesis: It remains unclear whether and which modality of exercise training as a component of lifestyle intervention may exert favourable effects on somatosensory and autonomic nerve tests in people with type 2 diabetes. Methods: Cardiovascular autonomic and somatosensory nerve function as well as intraepidermal nerve fibre density (IENFD) were assessed in overweight men with type 2 diabetes (type 2 diabetes, n = 20) and male glucose-tolerant individuals (normal glucose tolerance [NGT], n = 23), comparable in age and BMI and serving as a control group, before and after a supervised high-intensity interval training (HIIT) intervention programme over 12 weeks. Study endpoints included clinical scores, nerve conduction studies, quantitative sensory testing, IENFD, heart rate variability, postural change in systolic blood pressure and spontaneous baroreflex sensitivity (BRS). Results: After 12 weeks of HIIT, resting heart rate decreased in both groups ([mean ± SD] baseline/12 weeks: NGT: 65.1 ± 8.2/60.2 ± 9.0 beats per min; type 2 diabetes: 68.8 ± 10.1/63.4 ± 7.8 beats per min), while three BRS indices increased (sequence analysis BRS: 8.82 ± 4.89/14.6 ± 11.7 ms2/mmHg; positive sequences BRS: 7.19 ± 5.43/15.4 ± 15.9 ms2/mmHg; negative sequences BRS: 12.8 ± 5.4/14.6 ± 8.7 ms2/mmHg) and postural change in systolic blood pressure decreased (−13.9 ± 11.6/−9.35 ± 9.76 mmHg) in participants with type 2 diabetes, and two heart rate variability indices increased in the NGT group (standard deviation of R–R intervals: 36.1 ± 11.8/55.3 ± 41.3 ms; coefficient of R–R interval variation: 3.84 ± 1.21/5.17 ± 3.28) (all p<0.05). In contrast, BMI, clinical scores, nerve conduction studies, quantitative sensory testing, IENFD and the prevalence rates of diabetic sensorimotor polyneuropathy and cardiovascular autonomic neuropathy remained unchanged in both groups. In the entire cohort, correlations between the changes in two BRS indices and changes in $$ \dot{V}{\mathrm{O}}_{2\max } $$ V ̇ O 2 max over 12 weeks of HIIT (e.g. sequence analysis BRS: r = 0.528, p=0.017) were observed. Conclusions/interpretation: In male overweight individuals with type 2 diabetes, BRS, resting heart rate and orthostatic blood pressure regulation improved in the absence of weight loss after 12 weeks of supervised HIIT. Since no favourable effects on somatic nerve function and structure were observed, cardiovascular autonomic function appears to be more amenable to this short-term intervention, possibly due to improved cardiorespiratory fitness. Graphical

16 April 2018 in Acta Diabetologica
Verified
Journal Article
Closed access
PDF file
MAMaria Apostolopoulou
Maria Apostolopoulou
BMBarbara Menart-Houtermans
Barbara Menart-Houtermans
RRRuth Ruetter
Ruth Ruetter
BNBettina Nowotny
Bettina Nowotny
UGUlrich Gehrmann
Ulrich Gehrmann
MRMichael Roden
Michael Roden

1 January 2025 in Case Reports in Endocrinology
Verified
Journal Article
Open access
MAMaria Apostolopoulou
Maria Apostolopoulou
RTRobert Taayedi
Robert Taayedi
CSCosmin Paul Sărac
Cosmin Paul Sărac
FDFrank Demtröder
Frank Demtröder
A wide spectrum of clinical entities can lead to pre and postmenopausal hyperandrogenism, which is characterized by slow or more rapid onset of virilizing symptoms (menstrual irregularities, hirsutism, androgenetic alopecia). Functional hyperandrogenism in the context of polycystic ovary syndrome (PCOS) remains the most prevalent cause for hyperandrogenism both in pre and postmenopausal females; however, other clinical entities such as ovarian hyperthecosis and benign or malignant neoplasms (e.g., adrenal androgen‐secreting adenomas and ovarian tumors of androgen‐secreting cells) are often challenging to diagnose. Laboratory testing should include measurement of testosterone, sex hormone binding globulin (SHBG), gonadotropins, estradiol, androstenedione, dehydroepiandrosterone sulfate (DHEA‐S), and 17‐OH‐progesterone values, as well as markers of other endocrine disorders leading to secondary hyperandrogenism, especially Cushing’s syndrome. Testosterone values of more than 150 ng/dL generally require further investigation, and increased DHEA‐S (more than 700 μg/dL) is suggestive of adrenal androgen‐secreting tumors. Androgen suppression during prolonged dexamethasone test can facilitate differential diagnosis between adrenal and ovarian androgen excess production and point to autonomous production in case of tumors. In case of smaller ovarian tumors (e.g., Leydig cell), imaging might not be diagnostic, so that in case of high clinical suspicion, selective ovarian catheterization can be a valuable tool, when available. In this paper, we highlight four rare conditions of hyperandrogenism beyond PCOS, each reflecting specific stages or challenges across the female lifespan. We suggest that detailed biochemical testing and high clinical suspicion should promptly lead to valuable invasive diagnostic tools (ovarian catheterization/laparoscopy) in case imaging is not diagnostic.